SCIB1: Updated Phase I/II data

Updated data from 16 patients with fully resected stage III/IV metastatic melanoma in an open-label, U.K. Phase I/II trial showed that 4 mg intramuscular SCIB1 given at weeks 0, 3, 6, 12 and 24 led to...